Even though we did not observe ERBB2 overexpression at the transcript level, upstream analysis shows it as a common denominator for several of our up-regulated transcripts, which suggest an activated state of ERBB2 in CRC. The gene discussed is ERBB2; the disease is colorectal carcinoma.